Clinical Trial Update: A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II, single-arm multicenter trial evaluating apatinib in combination with adebrelimab and an etoposide/carboplatin regimen as first-line therapy for exte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: NOT_YET_RECRUITING